ARIPIPRAZOLE
- Product NDC
- 43547-302
- Requested package NDC
- 43547-302-50
- 11-digit product format
- 435470302
- Labeler code
- 43547
- Product ID
- 43547-302_30122f78-05e7-4d3f-8c36-03be911841de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aripiprazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Solco Healthcare U.S., LLC
- Application
- ANDA205363
- Marketing category
- ANDA
- Marketing start
- 2017-12-04
- Substance
- ARIPIPRAZOLE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205363-001 | ARIPIPRAZOLE | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | |
| A205363-002 | ARIPIPRAZOLE | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | |
| A205363-003 | ARIPIPRAZOLE | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | |
| A205363-004 | ARIPIPRAZOLE | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | |
| A205363-005 | ARIPIPRAZOLE | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | |
| A205363-006 | ARIPIPRAZOLE | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A205363-001 | AB |
| A205363-002 | AB |
| A205363-003 | AB |
| A205363-004 | AB |
| A205363-005 | AB |
| A205363-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205363-005 | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A205363-006 | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205363-005 | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A205363-006 | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205363-005 | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A205363-006 | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205363-005 | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205363-006 | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-005 | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-006 | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-005 | ARIPIPRAZOLE | 20MG | TABLET / ORAL | AB | 2017-12-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-006 | ARIPIPRAZOLE | 30MG | TABLET / ORAL | AB | 2017-12-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-001 | ARIPIPRAZOLE | 2MG | TABLET / ORAL | AB | 2017-12-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-002 | ARIPIPRAZOLE | 5MG | TABLET / ORAL | AB | 2017-12-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-003 | ARIPIPRAZOLE | 10MG | TABLET / ORAL | AB | 2017-12-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-004 | ARIPIPRAZOLE | 15MG | TABLET / ORAL | AB | 2017-12-04 | 6a471c1ec25d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A205363-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205363-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205363-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205363-004 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205363-005 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A205363-006 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A205363-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205363-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205363-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205363-004 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205363-005 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A205363-006 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A205363-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205363-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205363-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205363-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205363-005 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A205363-006 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A205363-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205363-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205363-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205363-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205363-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205363-006 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205363-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205363-006 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205363-004 | AB | 1 | 6a471c1ec25d… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ARIPIPRAZOLE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ARIPIPRAZOLE | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 82VFR53I78 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 686d0088-ac61-41df-8909-ae12f7957644 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 915afeb5-0b22-42c0-86ea-77abf1c5fe15 | Product name | 1 | 20250307 |
| 51c1e9bf-32c5-4a7b-b010-f93a90af7b6e | Product name | 1 | 20231010 |
| 34645f32-2ac4-41bf-9c61-8107e4764a26 | Product name | 1 | 20181210 |
| f8ff9e17-cd6c-4547-98c3-f5db0d1fc25d | Product name | 1 | 20180110 |
| 14eaf619-f285-4cd0-9f39-d9dd8f3d9c02 | Product name | 1 | 20170824 |
| 8223ef47-de85-24dd-a9c7-5a041d2634a2 | Product name | 9 | 20170223 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43547-302-03 | ARIPIPRAZOLE | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 43547-302-09 | ARIPIPRAZOLE | 90 in 1 BOTTLE | TABLET | 90 | 6 | |
| 43547-302-10 | ARIPIPRAZOLE | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 43547-302-50 | ARIPIPRAZOLE | 500 in 1 BOTTLE | TABLET | 500 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43547-302-03 | EA - Each | 43547-302 | 83594e9f-0018-4955-982b-258f1d611295 | 1 | 2018-02-20 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | Solco Healthcare U.S., LLC | 686d0088-ac61-41df-8909-ae12f7957644 | 2026-08-30 | Boxed warning, Warnings, Adverse reactions | 205363 ANDA205363 43547-302-50 43547-302 43547030250 |
| ARIPIPRAZOLE | ARIPIPRAZOLE | Solco Healthcare U.S., LLC | abb8ad7e-7998-4485-a09f-a2892190f4ad | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | 205363 ANDA205363 |
| ARIPIPRAZOLE | ARIPIPRAZOLE | A-S Medication Solutions | db6fc74e-4989-464d-9c19-a5b7a541fd46 | 2024-03-10 | Boxed warning, Warnings, Adverse reactions | 205363 ANDA205363 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43547-302-50 | 43547030250 | 500 TABLET in 1 BOTTLE (43547-302-50) | 500 tablet | 2017-12-04 | 0000-00-00 | No | No | Current |